Goldman Sachs reiterates Upstart stock rating on April origination data By Investing.com

Goldman Sachs kept a Neutral rating on Upstart with a $32 price target, but said April originations imply Q2 volumes of about $3.8B versus roughly $4B consensus, or about 4% below Street estimates. The firm flagged a moderate step-down in volume growth despite strong daily volumes, and will look to Upstart's May 5 earnings for further clarity. Separately, Upstart expanded loan purchase commitments with Fortress and Centerbridge, totaling $2.45B in new and extended forward-flow capacity.

Analysis

The key market read is not the headline on monthly originations, but the tightening gap between funded loan growth and what the market had priced as a re-acceleration story. That matters because Upstart’s equity multiple is still heavily dependent on the market believing its funding capacity can absorb higher origination volumes without choking contribution margin; if that bridge weakens even modestly, the stock can de-rate quickly because the balance between growth and unit economics is still fragile.

The bigger second-order signal is in credit distribution rather than in Upstart alone. Fortress and Centerbridge expanding forward-flow commitments tells us private credit and structured buyers are still willing to warehouse consumer risk, but the recent stress in adjacent consumer-loan vehicles suggests that risk appetite is becoming more selective, not broader. That creates a potential squeeze on lesser-quality originators and on public names like AFRM that are more exposed to funding-market sentiment, while reinforcing the advantage of platforms with diversified buyer bases and stronger loss data.

This is a near-term catalyst setup with a two-step horizon: the next few sessions will trade on interpretation of monthly volume, but the real swing factor is the upcoming earnings print, where the market will re-rate the durability of growth versus contribution profit. Consensus looks vulnerable to a downward revision cycle if management sounds even slightly more cautious on 2Q take-rate or partner demand, because the current narrative assumes volume resilience despite tougher comps. The contrarian angle is that the market may be overfocusing on headline originations and underappreciating that stronger funding commitments can keep the franchise alive longer, even if growth decelerates; that supports the long-term platform value but does not necessarily protect the stock from a 10-15% multiple reset first.

Key Decisions for Investors

• Short UPST into the May 5 earnings window or via a defined-risk put spread; risk/reward is attractive if management confirms sub-estimate 2Q originations and any moderation in contribution profit, with downside to the low-$30s or high-$20s if the market re-prices growth durability.
• Maintain or add to AFRM short exposure on any strength for the next 2-6 weeks; it has cleaner sensitivity to private-credit sentiment and could underperform UPST if consumer-loan warehouse stress keeps widening, with a tighter stop if broader credit spreads compress.
• Pairs trade: long GS / short UPST for 1-2 months; Goldman benefits if the market rotates toward capital-light fintech skepticism while maintaining exposure to structuring and capital-markets fees tied to forward-flow activity. This is lower beta and better for a risk-off tape.
• For more tactical traders, buy UPST May/June put spreads rather than outright shorting common; implied vol should stay supported into earnings, and the defined-risk structure gives better convexity if guidance disappoints.
• If UPST gaps down on earnings but confirms strong forward-flow demand, cover into weakness rather than pressing the short; that outcome would argue for a valuation reset rather than a fundamental break, limiting follow-through to one or two trading sessions.